Skip to main content
European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Contenuto archiviato il 2024-05-27

Functional anatomical molecular optical screening

Descrizione del progetto


Core and disruptive photonic technologies
FAMOS will develop a new generation of light sources with step-changes in performance beyond the state-of-the-art to radically transform biophotonic technologies for point-of-care diagnosis and functi

Biophotonics offers low-cost, non-invasive, accurate, rapid alternatives to conventional diagnostic methods and has the potential to address medical needs with early detection and to reduce the cost of healthcare. FAMOS will develop a new generation of light sources with step-changes in performance beyond the state-of-the-art to radically transform biophotonic technologies for point-of-care diagnosis and functional imaging. This will enable optical diagnostics with superior sensi-tivity, specificity, reliability and clinical utility at reduced cost, heralding an imaging renaissance in Europe.FAMOS addresses optical imaging from molecular over (sub)cellular to individual organs, with no gap in the arsenal of diagnostic tools for medical end-users. The world-class multidisciplinary FA-MOS team of 7 leading academic institutions and 10 top SMEs has unique complementary knowledge of optical coherence tomography, adaptive optics, photoacoustic tomography, coherent anti-stokes Raman scattering, multiphoton tomography as well as swept-source, diode-pumped ultrafast and tuneable nanosecond pulse lasers. Combinations of some techniques will offer multi-modal solutions to diagnostic needs that will exploit and enhance the benefits of each modality. FAMOS technologies have wide applicability, but our specific focus is on diagnosis in ophthalmol-ogy and oncology. Partnerships with leading innovative clinical users will enable preclinical evalua-tion.The objectives of FAMOS are:•\tDevelop new light sources with a step-change in performance (2-3 times more compact and up to 3-4 times cheaper diode pumped Ti:sapphire, 4-10 times faster swept sources and tuneable nanosecond pulse sources)•\tIntegrate these with optical imaging for a step-change in diagnosis (2-5 times better resolution cellular retinal imaging with more than 10 times larger field of view, up to 10 times enhanced penetration single source subcellular morphologic imaging, increased selectivity of intrinsic mo-lecular sensing as well as several frames per second deep tissue functional tomography•\tPerform preclinical studies to demonstrate novel or improved ophthalmic and skin cancer diag-nosis establishing novel biomarkers (melanocyte shape, NADPH, melanin concentration, Hb/HbO2 as well as lipid, water and DNA/RNA concentration)•\tEnable exceptional commercial opportunities for SMEs•\tProvide state-of-the-art academic training

Campo scientifico

Programma(i)

Argomento(i)

Invito a presentare proposte

FP7-ICT-2011-8
Vedi altri progetti per questo bando

Meccanismo di finanziamento

CP - Collaborative project (generic)

Coordinatore

MEDIZINISCHE UNIVERSITAET WIEN
Contributo UE
€ 1 145 404,00
Indirizzo
SPITALGASSE 23
1090 Wien
Austria

Mostra sulla mappa
Regione
Ostösterreich Wien Wien
Tipo di attività
Higher or Secondary Education Establishments
Contatto amministrativo
Wolfgang Drexler (Prof.)
Collegamenti
Costo totale
Nessun dato

Partecipanti (16)

Condividi questa pagina

Scarica

Ultimo aggiornamento: 22 Aprile 2017

Il mio fascicolo

Permalink: https://cordis.europa.eu/project/id/317744/it

European Union, 2024